Skip to content
10-K

Annual Report

Eledon Pharmaceuticals, Inc. ELDN

0001193125-26-116164

← back to feed
Filed
Mar 19, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 13, 2026 75.85M sh
Shares Diluted FY 2025 · Dec 31, 2025 81.84M sh
Shares Diluted FY 2025 · Dec 31, 2024 48.54M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$62.34M
Short Term Investments FY 2025 · Dec 31, 2025 $110.53M
Cash And Equivalents FY 2025 · Dec 31, 2025 $22.81M
Stockholders Equity FY 2025 · Dec 31, 2025 $81.09M
Current Liabilities FY 2025 · Dec 31, 2025 $18.34M
Total Liabilities FY 2025 · Dec 31, 2025 $32.23M
Current Assets FY 2025 · Dec 31, 2025 $135.69M
Total Assets FY 2025 · Dec 31, 2025 $169.01M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.52
Eps Diluted restated FY 2025 · Dec 31, 2024 −$0.66
Eps Basic FY 2025 · Dec 31, 2025 −$0.52
Eps Basic restated FY 2025 · Dec 31, 2024 −$0.66
Sga Expense FY 2025 · Dec 31, 2025 $16.98M
Rd Expense FY 2025 · Dec 31, 2025 $66.27M
Net Income FY 2025 · Dec 31, 2025 −$45.62M